Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $673.06M in the quarter ending August 31, 2026, with 8,426.27% growth. This brings the company's total for the last twelve months to $701.94M, up 738.76% year-over-year. In the fiscal year ending November 30, 2025, Nurix Therapeutics had annual revenue of $83.98M with 53.95% growth. That makes Nurix Therapeutics the 9,372nd largest company in the world by revenue and 2,053rd in the United States.

• Revenue (ttm): $701.94M
• Revenue Growth: +738.76%
• P/S Ratio: 4.17
• Revenue / Employee: $2,214,309
• Employees: 317
• Market Cap: 2.93B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2025	83.98M	29.43M	53.95%
Nov 30, 2024	54.55M	-22.44M	-29.15%
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%
Nov 30, 2019	31.12M	-6.33M	-16.91%
Nov 30, 2018	37.45M	-	-

Data Source: Fiscal.ai Last updated: Oct 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error